THL to Acquire Headlands Research From KKR

Paul, Weiss is advising THL Partners on the financing aspects of its acquisition of Headlands Research, a leading multinational network of clinical trial sites, from funds managed by KKR. The strategic partnership between THL and Headlands will fuel Headlands’ continued expansion, enhance its technology and centralized infrastructure, and further strengthen its ability to deliver high-quality, diverse clinical trial data for pharmaceutical and biotech sponsors.

THL will invest in Headlands through its flagship Fund IX. The transaction is expected to close in 2025, subject to the satisfaction of customary closing conditions.

The Paul, Weiss team is led by corporate partners Eric Wedel, Matthew Leist and Caroline Epstein.